下一代基于抗体的癌症治疗:抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用 Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors PubMed 2026/09/09 发表J Hematol OncolQ1 · IF 47.8(JCR 2025) 靶点:CD19靶点:CD20靶点:BCMA技术:CAR-T技术:双特异性抗体急性淋巴细胞白血病多发性骨髓瘤B细胞淋巴瘤
肾功能下降预测大 B 细胞淋巴瘤 CAR-T 细胞治疗后重度细胞因子释放综合征 Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma. PubMed 2026/04/15 发表Br J HaematolQ2 · IF 3.6(JCR 2025) 靶点:CD19靶点:EGFR技术:CAR-T大B细胞淋巴瘤淋巴瘤地区:日本
迈向个体化淋巴细胞清除:接受 CAR-T 细胞治疗患者的群体药代动力学氟达拉滨模型 Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy. PubMed 2025/12/10 发表PharmaceuticsQ1 · IF 6.9(JCR 2025) 靶点:EGFR技术:CAR-T技术:造血干细胞大B细胞淋巴瘤淋巴瘤地区:欧洲